ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2347

Specificity of the New American College of Rheumatology/European League Against Rheumatism Classification Criteria for Polymyalgia Rheumatica in Comparison with the Former Ones : A Single Centre Study

Pierluigi Macchioni1, Luigi Boiardi2, Mariagrazia Catanoso3, Giulia Pazzola4 and Carlo Salvarani5, 1Rheumatology Service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Servizio Di Reumatologia, Arcispedale S Maria Nuova, Reggio Emilia, Italy, 3Rheumatology Unit, Arcispedale S Maria Nuova, Reggio Emilia, Italy, 4Rheumatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy, 5Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Classification criteria and polymyalgia rheumatica

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

To evaluate the specificity of the new ACR/EULAR classification criteria for PMR in a consecutive series of outpatients attending an early arthritis clinic (EAC).

Methods:

All patients attending our outpatients EAC are followed according to a standardized protocol which include clinical examination, determination of laboratory parameters, quality of life questionnaires and ultrasound (US) examination of shoulders, hips, hands and feet. In this 3-year prospective study we included consecutive patients aged > 50 years followed for at least 12 months. Patients entered the study if they had a definite diagnosis of non-PMR inflammatory joint condition confirmed at 12 month follow-up period according to rheumatologist opinion (PM). The PMR group consisted of 136 recent onset, consecutive patients seen in our rheumatological centre during a 5 year period. C statistic were utilized to compare the new ACR/EULAR classification criteria with some of the former diagnostic/classification criteria (Hunder’s, Jones’s, Bird’s, Healey’s criteria). 

Results:

One hundred and twenty-eight non PMR patients entered the study (mean age 64.2+9.9y, female 70.3%, mean disease duration at first visit 12.47+9.0 w, mean ESR 35.13+25.3 mm/1sth, mean CRP 2.04+2.48 mg/dl). After one year of follow up their diagnosis was : rheumatoid arthritis (RA) 96 pts, spondyloarthropaty 32 pts.

Table 1 shows the specificity and area under the curve (AUC) of the receiver operating characteristic curves when conditions were met in the total group and in the RA patients group(*).

Specificity and AUC in the total group and in the rheumatoid arthritis patients group(*)

PMR diagnostic

/classification criteria

Specificity

(128 total cases)

AUC

(SE)

Specificity*

(96 RA patients)

AUC*

(SE)

ACR/EULAR

81.5

0.872(.029)

79.7

0.863(.031)

US-ACR /EULAR

91.4

0.917(.023)

89.9

0.910(.025)

HEALEY

80.2

0.799(.033)

78.3

0.773(.035)

HUNDER

79.0

0.777(.034)

78.3

0.789(.036)

BIRD

72.8

0.742(.036)

72.5

0.740(.038)

JONES

96.7

0.810(.030)

98.6

0.816(.030)

Conclusion:

In a series of outpatients attending our EAC the new ACR/EULAR PMR classification criteria have a better specificity as compared to the previous criteria (except for Jones’s one). US shoulders and hips examination increases the specificity of the new ACR/EULAR criteria.


Disclosure:

P. Macchioni,
None;

L. Boiardi,
None;

M. Catanoso,
None;

G. Pazzola,
None;

C. Salvarani,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/specificity-of-the-new-american-college-of-rheumatologyeuropean-league-against-rheumatism-classification-criteria-for-polymyalgia-rheumatica-in-comparison-with-the-former-ones-a-single-centre-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology